Erythropoietin is present in the cerebrospinal fluid of neonates☆,☆☆,★,★★
Section snippets
CSF specimens
Spinal fluid was obtained from 50 neonates ranging in gestational age from 24 weeks to term. Twenty-three of these neonates were treated with rEpo at the discretion of the attending neonatologist. Two neonates had meningitis and were considered separately. Thirty additional spinal fluid samples from patients aged 1 month to 60 years of age, none of whom were receiving rEpo treatment, were assayed. All samples were obtained from the clinical laboratory of Shands Teaching Hospital after patients
RESULTS
Epo was present in the spinal fluid of premature and term neonates in the absence of rEpo treatment, meningitis, or intracranial hemorrhage (Figure).
DISCUSSION
Epo is a 34,000-dalton glycoprotein that, on the basis of size, is unlikely to cross the blood-brain barrier in the absence of a carrier molecule. It is possible, however, that in the presence of an extremely immature blood-brain barrier, asphyxia, acidosis, or meningitis, or after an intraventricular hemorrhage, the blood-brain barrier might be more likely to permit the transfer of large molecules such as Epo. We observed that Epo was present in the CSF of normal preterm and term infants in
References (12)
- et al.
Receptors for erythropoietin in mouse and human erythroid cells and placenta
Blood
(1989) - et al.
A novel site of erythropoietin production
J Biol Chem
(1994) - et al.
Tissue specific expression of human erythropoietin receptor in transgenic mice
Dev Biol
(1994) - et al.
Trophic effect of erythropoietin and other hematopoietic factors on central cholinergic neurons in vitro and in vivo
Brain Res
(1993) - et al.
Pharmacokinetics and effectiveness of recombinant erythropoietin administered to preterm infants by continuous infusion in parenteral nutrition solution
J Pediatr
(1996) - et al.
Erythropoietin receptor mRNA expression in human endothelial cells
Proc Natl Acad Sci U S A
(1994)
Cited by (0)
- ☆
From the Division of Neonatology, Department of Pediatrics, University of Florida College of Medicine, Gainesville.
- ☆☆
Supported by grants MCAP RR-00083 and HL-44951 from the National Institutes of Health and by a grant from the Children's Miracle Network.
- ★
Reprint requests: Sandra Juul, MD, Division of Neonatology, University of Florida College of Medicine, PO Box 100296, J. Hillis Miller Health Center, Gainesville, FL 32610-0296.
- ★★
0022-3476/97/$5.00 + 0 9/21/77829